Is there a generic version of Ceritinib/Ceritinib and its market availability?
Ceritinib (Ceritinib) is a targeted drug used to treat ALK positive non-small cell lung cancer. It has been officially launched in China and has been included in the medical insurance system. Domestic patients can purchase original drugs through regular hospital pharmacies to ensure reliable drug sources and safe use. Since it has not been on the market for long, there may be short-term supply shortages in some areas. It is recommended that patients consult the hospital or pharmacy in advance for specific purchase information.
Regarding generic drugs, there is currently no domestically produced generic version of ceritinib approved in China, so patients mainly rely on imported original drugs. In the foreign market, generic drugs of ceritinib have been launched in Laos and other places. Its drug ingredients are basically the same as the original drug, but the price is relatively low, only about more than 1,000 yuan. Such generic drugs provide more choices for patients under financial pressure, but they must pay attention to purchasing through formal channels to ensure drug quality and safety.
In terms of market availability, the domestic supply of original ceritinib is relatively stable, and patients can obtain it through formal channels. Although overseas generic drugs are cheaper, they are subject to cross-border drug purchase policies, transportation and customs restrictions, making them difficult to obtain and requiring patients to operate with caution. At the same time, you should understand the legality and safety of drugs before purchasing overseas drugs to avoid buying counterfeit or inferior drugs.
Overall, ceritinib is mainly an original drug in the domestic market, and medical insurance coverage improves patient accessibility. Overseas generic drugs have price advantages, but their actual availability and convenience of use are not as good as domestic drugs. Therefore, when choosing a drug purchase channel, patients should comprehensively consider price, legality and medication safety, and give priority to regular hospital pharmacies to ensure treatment effects and medication safety.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)